Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type | Tumor Size |
A1 | 1 | 43 | F | Breast | Invasive carcinoma of no special type with sparse necrosis | 1 | T3N0M0 | IIB | Malignant | 5*3 |
A2 | 2 | 75 | F | Breast | Invasive carcinoma of no special type | 1 | T3N1M0 | IIIA | Malignant | 12*9 |
A3 | 3 | 32 | F | Breast | Invasive carcinoma of no special type | 1--2 | T3N1M0 | IIIA | Malignant | 12*8 |
A4 | 4 | 55 | F | Breast | Invasive carcinoma of no special type | 1--2 | T4N1M0 | IIIB | Malignant | 3*3*2.5 |
A5 | 5 | 52 | F | Breast | Invasive carcinoma of no special type | 2 | T2N0M0 | IIA | Malignant | * |
A6 | 6 | 54 | F | Breast | Invasive carcinoma of no special type | 2 | T2N1M0 | IIB | Malignant | 3*2.5*1.0 |
A7 | 7 | 48 | F | Breast | Invasive carcinoma of no special type | 2 | T3N0M0 | IIB | Malignant | 7*5*2.5 |
A8 | 8 | 30 | F | Breast | Invasive carcinoma of no special type | 2 | T2N0M0 | IIA | Malignant | 3.5*2.5*1.0 |
A9 | 9 | 54 | F | Breast | Invasive carcinoma of no special type | 2 | T3N0M0 | IIB | Malignant | 3.0*3.0*2.5 |
A10 | 10 | 55 | F | Breast | Invasive carcinoma of no special type (sparse) | 2 | T2N2M0 | IIIA | Malignant | * |
A11 | 11 | 29 | F | Breast | Invasive carcinoma of no special type (interstitial) | 2 | T2N0M0 | IIA | Malignant | * |
A12 | 12 | 87 | F | Breast | Invasive carcinoma of no special type | 2 | T2N1M0 | IIB | Malignant | 5*5 |
A13 | 13 | 44 | F | Breast | Invasive carcinoma of no special type | 2 | T2N2M0 | IIIA | Malignant | 2.5*1*1 |
A14 | 14 | 42 | F | Breast | Invasive carcinoma of no special type | 2 | T2N1M0 | IIB | Malignant | 5*4*2.5 |
A15 | 15 | 52 | F | Breast | Invasive carcinoma of no special type (sparse) | 2 | T2N1M0 | IIB | Malignant | 2*2 |
A16 | 16 | 42 | F | Breast | Invasive carcinoma of no special type (sparse) | 2 | T4N2M0 | IIIB | Malignant | 6*6*2 |
B1 | 17 | 55 | F | Breast | Invasive carcinoma of no special type | 2 | T3N2M0 | IIIB | Malignant | * |
B2 | 18 | 43 | F | Breast | Invasive carcinoma of no special type | 2 | T2N1M0 | IIB | Malignant | * |
B3 | 19 | 37 | F | Breast | Invasive carcinoma of no special type with degeneration | 2 | T2N1M0 | IIB | Malignant | 2.5*2*2 |
B4 | 20 | 38 | F | Breast | Invasive carcinoma of no special type | 2 | T3N0M0 | IIB | Malignant | 5*4 |
B5 | 21 | 48 | F | Breast | Invasive carcinoma of no special type | 2 | T2N2M0 | IIIA | Malignant | 2*2 |
B6 | 22 | 37 | F | Breast | Invasive carcinoma of no special type | 2 | T2N2M0 | IIIA | Malignant | 5*3*2 |
B7 | 23 | 48 | F | Breast | Invasive carcinoma of no special type | 2 | T1N1M0 | IIA | Malignant | * |
B8 | 24 | 46 | F | Breast | Invasive carcinoma of no special type (interstitial) | 2 | T3N2M0 | IIIA | Malignant | 9*5 |
B9 | 25 | 68 | F | Breast | Invasive carcinoma of no special type | 2 | T3N0M0 | IIB | Malignant | 17*9*5 |
B10 | 26 | 51 | F | Breast | Invasive carcinoma of no special type | 2 | T2N2M0 | IIIA | Malignant | 3*3 |
B11 | 27 | 52 | F | Breast | Invasive carcinoma of no special type | 2 | T4N1M0 | IIIB | Malignant | 7*3 |
B12 | 28 | 52 | F | Breast | Invasive carcinoma of no special type | 2 | T3N1M0 | IIIA | Malignant | 5*4.5 |
B13 | 29 | 42 | F | Breast | Invasive carcinoma of no special type | 2 | T3N0M0 | IIB | Malignant | 6*5*4 |
B14 | 30 | 41 | F | Breast | Invasive carcinoma of no special type (containing ductal carcinoma in situ) | 2 | T2N0M0 | IIA | Malignant | 5*2.2 |
B15 | 31 | 47 | F | Breast | Invasive carcinoma of no special type | 2 | T4N1M0 | IIIB | Malignant | 2.5*2*2 |
B16 | 32 | 32 | F | Breast | Invasive carcinoma of no special type with sparse necrosis | 2 | T4N1M0 | IIIB | Malignant | 5*3*3 |
C1 | 33 | 32 | F | Breast | Invasive carcinoma of no special type with degeneration | 2 | T2N1M0 | IIB | Malignant | 5*3 |
C2 | 34 | 53 | F | Breast | Invasive carcinoma of no special type | 2--3 | T2N2M0 | IIIA | Malignant | 4*3* |
C3 | 35 | 59 | F | Breast | Invasive carcinoma of no special type | 2--3 | T2N0M0 | IIA | Malignant | :6*4.5*3.0 |
C4 | 36 | 38 | F | Breast | Invasive carcinoma of no special type with sparse necrosis | 2--3 | T2N0M0 | IIA | Malignant | * |
C5 | 37 | 51 | F | Breast | Invasive carcinoma of no special type with sparse necrosis | 3 | T3N1M0 | IIIA | Malignant | 6*4.5*3.0 |
C6 | 38 | 58 | F | Breast | Invasive carcinoma of no special type | 3 | T2N1M0 | IIB | Malignant | * |
C7 | 39 | 63 | M | Lung | Squamous cell carcinoma with sparse necrosis | 1 | T2N0M0 | IB | Malignant | 5*4*3.5 |
C8 | 40 | 53 | M | Lung | Squamous cell carcinoma | 1 | T2N1M0 | II | Malignant | 6.3*5*5 |
C9 | 41 | 55 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant | 5.5*4.0*3.0 |
C10 | 42 | 60 | M | Lung | Squamous cell carcinoma | 2 | T2N2M0 | IIIA | Malignant | 4.5*3.0*3.0 |
C11 | 43 | 58 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant | 4.5*4.0*3.0 |
C12 | 44 | 55 | M | Lung | Squamous cell carcinoma (sparse) | 2 | T2aN1M0 | IIA | Malignant | 5.0*4.0*3.5 |
C13 | 45 | 55 | F | Lung | Squamous cell carcinoma (sparse) | 2 | T2aN0M0 | IB | Malignant | 5.0 |
C14 | 46 | 63 | M | Lung | Squamous cell carcinoma with necrosis | 2 | T2N0M0 | IB | Malignant | 6.0*5.0*4.5 |
C15 | 47 | 48 | M | Lung | Squamous cell carcinoma with necrosis | 2 | T2aN0M0 | IB | Malignant | 3.5*3.0*2.0 |
C16 | 48 | 54 | M | Lung | Squamous cell carcinoma (sparse) | 2 | T2aN0M0 | IB | Malignant | 4.5*3.0*3.0 |
D1 | 49 | 61 | M | Lung | Squamous cell carcinoma | 2 | T2N1M0 | IIA | Malignant | 5.0*3.0*3.0 |
D2 | 50 | 42 | F | Lung | Squamous cell carcinoma (necrosis) | * | T2aN0M0 | IB | Malignant | 4.0*3.5*2.0 |
D3 | 51 | 35 | F | Lung | Squamous cell carcinoma | 2 | T2aN0M0 | IB | Malignant | 4.5*3.5*3.0 |
D4 | 52 | 48 | F | Lung | Squamous cell carcinoma with sparse necrosis | 2 | T2bN0M0 | IIA | Malignant | 4.5*4.5*4.0 |
D5 | 53 | 58 | M | Lung | Squamous cell carcinoma (sparse) | 2 | T2aN0M0 | IB | Malignant | 4.0*3.5*2.0 |
D6 | 54 | 51 | M | Lung | Squamous cell carcinoma with necrosis | 2 | T2aN0M0 | IB | Malignant | 5.0*5.0*3.5 |
D7 | 55 | 60 | F | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant | 3.0*2.5*2.5 |
D8 | 56 | 46 | F | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant | 4.5*4.0*3.0 |
D9 | 57 | 57 | M | Lung | Squamous cell carcinoma | 2 | T2N1M0 | IIB | Malignant | 7.5*6*2 |
D10 | 58 | 57 | F | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant | 4.8*4*2.8 |
D11 | 59 | 71 | M | Lung | Squamous cell carcinoma | 2 | T2bN1M0 | IIB | Malignant | 6*5.8*3.5 |
D12 | 60 | 68 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant | 5*4*3 |
D13 | 61 | 70 | M | Lung | Squamous cell carcinoma | 2 | T2AN0M0 | IB | Malignant | 5*4.0*3.0 |
D14 | 62 | 56 | M | Lung | Squamous cell carcinoma (lung tissue) | * | T2N0M0 | IB | Malignant | * |
D15 | 63 | 58 | M | Lung | Squamous cell carcinoma | 3 | T2N3M0 | IIIB | Malignant | 5.0*4.0*3.5 |
D16 | 64 | 59 | M | Lung | Squamous cell carcinoma | 3 | T2N1M0 | IIB | Malignant | 6.5*5.0*4.0 |
E1 | 65 | 56 | M | Lung | Squamous cell carcinoma | 2--3 | T2N0M0 | IB | Malignant | 5*4*3.5 |
E2 | 66 | 49 | M | Lung | Squamous cell carcinoma | 3 | T2N1M0 | IIA | Malignant | 4.5*4 |
E3 | 67 | 42 | M | Lung | Squamous cell carcinoma with degeneration | 3 | T2N0M0 | IB | Malignant | 5*4 |
E4 | 68 | 60 | M | Lung | Squamous cell carcinoma | 3 | T3N1M0 | IIIA | Malignant | 6.0 |
E5 | 69 | 50 | M | Lung | Squamous cell carcinoma | * | T2aN0M0 | IB | Malignant | 4.0*2.5*2.0 |
E6 | 70 | 65 | M | Lung | Squamous cell carcinoma | 3 | T2bN0M0 | IIA | Malignant | 5.0*3.5*2.5 |
E7 | 71 | 66 | M | Lung | Squamous cell carcinoma | 3 | T2aN0M0 | IB | Malignant | 4.0*4.0*2.5 |
E8 | 72 | 57 | M | Lung | Squamous cell carcinoma with degeneration | 3 | T3N0M0 | IIB | Malignant | 8.0*5.0*3.5 |
E9 | 73 | 74 | M | Lung | Squamous cell carcinoma | 3 | T2bN0M0 | IIA | Malignant | 4.0*4.0*2.5 |
E10 | 74 | 46 | M | Lung | Squamous cell carcinoma with necrosis | 3 | T3N1M0 | IIIA | Malignant | 5.5 |
E11 | 75 | 57 | M | Lung | Squamous cell carcinoma | 3 | T2bN0M0 | IIA | Malignant | 5.0*4.5*4.0 |
E12 | 76 | 48 | M | Lung | Squamous cell carcinoma (chronic inflammation of lung tissue) | * | T2aN0M0 | IB | Malignant | 4.0*3.0*2.5 |
E13 | 77 | 77 | M | Colon | Adenocarcinoma | 1 | T2N0M0 | I | Malignant | * |
E14 | 78 | 76 | F | Colon | Adenocarcinoma | 1 | T3N0M0 | IIA | Malignant | * |
E15 | 79 | 54 | M | Colon | Adenocarcinoma (interstitial) | * | T3N0M0 | IIA | Malignant | * |
E16 | 80 | 72 | M | Colon | Adenocarcinoma | 1--2 | T3N0M0 | IIA | Malignant | 5*5*2 |
F1 | 81 | 60 | M | Colon | Adenocarcinoma (necrosis) | 1--2 | T3N0M0 | IIA | Malignant | * |
F2 | 82 | 87 | M | Colon | Adenocarcinoma | 1--2 | T2N0M0 | IB | Malignant | 4.5*3*1 |
F3 | 83 | 62 | F | Colon | Adenocarcinoma | 2 | T3N1M0 | IIIB | Malignant | * |
F4 | 84 | 65 | M | Colon | Adenocarcinoma | 2 | T3N2M0 | IIIB | Malignant | * |
F5 | 85 | 48 | M | Colon | Adenocarcinoma (sparse) | 2 | T3N0M0 | IIA | Malignant | * |
F6 | 86 | 72 | M | Colon | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant | * |
F7 | 87 | 35 | F | Colon | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant | * |
F8 | 88 | 72 | F | Colon | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant | * |
F9 | 89 | 46 | M | Colon | Adenocarcinoma (part mucinous adenocarcinoma) | 2 | T3N1M0 | IIIB | Malignant | * |
F10 | 90 | 56 | F | Colon | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant | * |
F11 | 91 | 58 | M | Colon | Adenocarcinoma | 2 | T3N2M0 | IIIC | Malignant | 6.5*4.5*1.5 |
F12 | 92 | 30 | M | Colon | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant | 6.5*4.5*1.0 |
F13 | 93 | 63 | F | Colon | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant | 4.5*4.0*0.5 |
F14 | 94 | 75 | F | Colon | Adenocarcinoma with degeneration | 2 | T3N0M0 | IIA | Malignant | 6*5*6 |
F15 | 95 | 56 | M | Colon | Adenocarcinoma | 2 | T3N2M0 | IIIC | Malignant | * |
F16 | 96 | 73 | F | Colon | Adenocarcinoma | 2 | T3N2aM0 | IIIB | Malignant | 3*3*0.5 |
G1 | 97 | 71 | M | Colon | Adenocarcinoma (part mucinous adenocarcinoma) | 2 | T4aN0M0 | IIB | Malignant | * |
G2 | 98 | 56 | M | Colon | Adenocarcinoma | 2 | T4aN0M0 | IIB | Malignant | * |
G3 | 99 | 64 | F | Colon | Adenocarcinoma | 2 | T4aN0M0 | IIB | Malignant | 5.5*5.0*2.5 |
G4 | 100 | 63 | M | Colon | Adenocarcinoma with sparse necrosis | 2 | T4aN1M0 | IIIB | Malignant | 5.0*4.0*1.5 |
G5 | 101 | 50 | F | Colon | Adenocarcinoma | 2 | T4aN2bM0 | IIIC | Malignant | 6*5*6 |
G6 | 102 | 66 | M | Colon | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant | 4.5*4.0*0.5 |
G7 | 103 | 73 | M | Colon | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant | 4.5*4.5*0.5 |
G8 | 104 | 69 | M | Colon | Adenocarcinoma (mucosa tissue) | 2 | T3N0M0 | IIA | Malignant | * |
G9 | 105 | 33 | M | Colon | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant | * |
G10 | 106 | 39 | F | Colon | Adenocarcinoma with sparse necrosis | 2 | T3N0M0 | IIA | Malignant | * |
G11 | 107 | 52 | M | Colon | Adenocarcinoma (part mucinous adenocarcinoma) | 2 | T3N0M0 | IIA | Malignant | * |
G12 | 108 | 64 | M | Colon | Adenocarcinoma (part mucinous adenocarcinoma) | 2 | T3N0M0 | IIA | Malignant | * |
G13 | 109 | 45 | F | Colon | Adenocarcinoma (part mucinous adenocarcinoma) | 2 | T3N0M0 | IIA | Malignant | * |
G14 | 110 | 65 | F | Colon | Adenocarcinoma (part mucinous adenocarcinoma) | 2 | T3N0M0 | IIA | Malignant | * |
G15 | 111 | 65 | M | Colon | Adenocarcinoma with sparse necrosis | 2 | 7T4N0M0 | IIB | Malignant | 3*3.5 |
G16 | 112 | 65 | F | Colon | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant | 4*3.0*0.5 |
H1 | 113 | 50 | M | Colon | Adenocarcinoma with sparse necrosis | 3 | T3N2M0 | IIIB | Malignant | 6.5*4.5*0.5 |
H2 | 114 | 60 | F | Colon | Adenocarcinoma | 3 | T3N1M0 | III | Malignant | 5*7*5 |
H3 | 115 | 71 | M | Prostate | Adenocarcinoma | * | T2N0M0 | I | Malignant | * |
H4 | 116 | 66 | M | Prostate | Adenocarcinoma | * | T2N0M0 | II | Malignant | 6*5*4 |
H5 | 117 | 60 | M | Prostate | Adenocarcinoma | * | T4N1M1 | IV | Malignant | * |
H6 | 118 | 76 | M | Prostate | Adenocarcinoma | * | T3bN0M0 | III | Malignant | * |
H7 | 119 | 69 | M | Prostate | Adenocarcinoma | * | T3N0M0 | III | Malignant | 4*3*2 |
H8 | 120 | 73 | M | Prostate | Adenocarcinoma | * | T3N0M0 | III | Malignant | * |
H9 | 121 | 63 | M | Prostate | Adenocarcinoma | * | T3N1M1 | IV | Malignant | * |
H10 | 122 | 60 | M | Prostate | Adenocarcinoma | * | T2N0M0 | II | Malignant | 4.5*4*2 |
H11 | 123 | 68 | M | Prostate | Adenocarcinoma | * | T2bN0M0 | IIA | Malignant | 8*7*5 |
H12 | 124 | 73 | M | Prostate | Adenocarcinoma | * | T2N0M0 | II | Malignant | 4*3.5*3 |
H13 | 125 | 73 | M | Prostate | Adenocarcinoma | * | T2aN0M0 | IIA | Malignant | * |
H14 | 126 | 62 | M | Prostate | Adenocarcinoma | * | T3N0M0 | III | Malignant | 4*3*3 |
H15 | 127 | 60 | M | Prostate | Adenocarcinoma | * | T2N0M0 | IIB | Malignant | 3*3*3 |
H16 | 128 | 80 | M | Prostate | Adenocarcinoma | * | T3N0M0 | III | Malignant | * |
I1 | 129 | 66 | M | Prostate | Adenocarcinoma | * | T2N0M0 | I | Malignant | 3*2*1 |
I2 | 130 | 70 | M | Prostate | Adenocarcinoma | * | T2aN0M0 | IIA | Malignant | 4*2*2 |
I3 | 131 | 75 | M | Prostate | Adenocarcinoma | * | T2N0M0 | II | Malignant | * |
I4 | 132 | 61 | M | Prostate | Adenocarcinoma | * | T3N1M0 | III | Malignant | * |
I5 | 133 | 69 | M | Prostate | Adenocarcinoma | * | T2aN0M0 | IIA | Malignant | 6*6*4.5 |
I6 | 134 | 57 | M | Prostate | Adenocarcinoma (sparse) | * | T2aN0M0 | IIA | Malignant | 3*4*4 |
I7 | 135 | 70 | M | Prostate | Adenocarcinoma | * | T3N0M0 | III | Malignant | 7*4*2.5 |
I8 | 136 | 70 | M | Prostate | Adenocarcinoma | * | T3N0M0 | III | Malignant | 7*3*3.5 |
I9 | 137 | 20 | M | Prostate | Adenocarcinoma | * | T3N0M0 | III | Malignant | 6*5*4 |
I10 | 138 | 62 | M | Prostate | Adenocarcinoma | * | T3N0M0 | III | Malignant | * |
I11 | 139 | 75 | M | Prostate | Adenocarcinoma | * | T2N0M0 | II | Malignant | * |
I12 | 140 | 72 | M | Prostate | Adenocarcinoma | * | T3N0M0 | III | Malignant | * |
I13 | 141 | 60 | M | Prostate | Adenocarcinoma (interstitial) | * | T3AN0M0 | III | Malignant | * |
I14 | 142 | 72 | M | Prostate | Adenocarcinoma | * | T2N0M0 | II | Malignant | 5*3*2 |
I15 | 143 | 74 | M | Prostate | Adenocarcinoma | * | T2N0M0 | II | Malignant | 6*4*3 |
I16 | 144 | 60 | M | Prostate | Adenocarcinoma | * | T3N0M0 | III | Malignant | * |
J1 | 145 | 65 | M | Prostate | Adenocarcinoma | * | T2N0M0 | II | Malignant | 3*3*2 |
J2 | 146 | 56 | M | Prostate | Adenocarcinoma | * | T3N0M0 | III | Malignant | 3*2.5 |
J3 | 147 | 82 | M | Prostate | Adenocarcinoma | * | T2bN0M0 | IIA | Malignant | * |
J4 | 148 | 81 | M | Prostate | Adenocarcinoma | * | T3aN0M0 | III | Malignant | 6*5*4 |
J5 | 149 | 66 | M | Prostate | Adenocarcinoma | * | T3aN0M0 | III | Malignant | 4.5*4*4 |
J6 | 150 | 63 | M | Prostate | Adenocarcinoma (degeneration) | * | T2N0M0 | II | Malignant | * |
J7 | 151 | 68 | M | Prostate | Adenocarcinoma | * | T2N0M0 | IIA | Malignant | 5*4*4 |
J8 | 152 | 75 | M | Prostate | Adenocarcinoma | * | T3N1M0 | III | Malignant | 5*2*2 |
J9 | 153 | 58 | F | Pancreas | Adenocarcinoma with necrosis | 1 | T3N1M0 | IIB | Malignant | * |
J10 | 154 | 31 | F | Pancreas | Adenocarcinoma | 1 | T3N1M0 | IIB | Malignant | 4*2*1 |
J11 | 155 | 42 | M | Pancreas | Adenocarcinoma | 1 | T2N0M0 | IB | Malignant | * |
J12 | 156 | 44 | F | Pancreas | Adenocarcinoma | 1 | T3N1M0 | IIB | Malignant | * |
J13 | 157 | 40 | M | Pancreas | Adenocarcinoma | 1 | T2N1M0 | IIB | Malignant | * |
J14 | 158 | 56 | F | Pancreas | Adenocarcinoma | 1--2 | T3N1M0 | IIB | Malignant | * |
J15 | 159 | 59 | M | Pancreas | Adenocarcinoma | 2 | T2N1M0 | IIB | Malignant | * |
J16 | 160 | 62 | M | Pancreas | Adenocarcinoma | 2 | T3N1M0 | IIB | Malignant | * |
K1 | 161 | 77 | M | Pancreas | Adenocarcinoma (sparse) | 2 | T1N0M0 | IA | Malignant | * |
K2 | 162 | 76 | M | Pancreas | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant | * |
K3 | 163 | 62 | M | Pancreas | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant | 3*3*3 |
K4 | 164 | 55 | M | Pancreas | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant | * |
K5 | 165 | 80 | M | Pancreas | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant | * |
K6 | 166 | 54 | M | Pancreas | Adenocarcinoma | 2 | T4N0M0 | III | Malignant | * |
K7 | 167 | 52 | M | Pancreas | Adenocarcinoma | 2--3 | T2N0M0 | I | Malignant | 3.5*3 |
K8 | 168 | 62 | F | Pancreas | Adenocarcinoma | 3 | T3N0M0 | IIA | Malignant | * |
K9 | 169 | 39 | F | Pancreas | Adenocarcinoma | 2--3 | T3N0M0 | IIA | Malignant | 4*3*1 |
K10 | 170 | 66 | F | Pancreas | Adenocarcinoma | 3 | T3N1M0 | IIB | Malignant | * |
K11 | 171 | 62 | F | Pancreas | Adenocarcinoma | 3 | T3N0M0 | IIA | Malignant | 6*5*4 |
K12 | 172 | 56 | M | Pancreas | Adenocarcinoma with neuroendocrine cancer differentiation | 3 | T2N0M0 | IB | Malignant | 9*8*6 |
K13 | 173 | 55 | M | Pancreas | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant | 5*4*2 |
K14 | 174 | 55 | M | Pancreas | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant | * |
K15 | 175 | 50 | M | Pancreas | Adenocarcinoma (degeneration) | 3 | T3N1M0 | IIB | Malignant | 5*4*2 |
K16 | 176 | 61 | F | Pancreas | Adenocarcinoma (necrosis) | 3 | T2N0M0 | IB | Malignant | * |
L1 | 177 | 64 | M | Pancreas | Adenocarcinoma (degeneration) | 3 | T3N0M0 | IIA | Malignant | 4*4*2 |
L2 | 178 | 69 | M | Pancreas | Adenocarcinoma with degeneration and necrosis | 2--3 | T2N0M0 | IB | Malignant | 10*3.5*3 |
L3 | 179 | 49 | M | Pancreas | Papillary cystadenocarcinoma | * | T2N0M0 | IB | Malignant | * |
L4 | 180 | 34 | M | Pancreas | Undifferentiated carcinoma | * | T2N1M0 | IIB | Malignant | * |
L5 | 181 | 54 | M | Pancreas | Adenosquamous carcinoma | * | T2N0M0 | IB | Malignant | 3*3*2 |
L6 | 182 | 51 | F | Pancreas | Adenosquamous carcinoma with necrosis | * | T2N0M0 | IB | Malignant | 7*6*4 |
L7 | 183 | 59 | M | Pancreas | Adenosquamous carcinoma | * | T3N1M0 | IIB | Malignant | * |
L8 | 184 | 62 | F | Pancreas | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant | 4*3*2.5 |
L9 | 185 | 62 | M | Pancreas | Squamous cell carcinoma | 3 | T3N0M0 | IIA | Malignant | 6*5 |
L10 | 186 | 67 | M | Pancreas | Neuroendocrine carcinoma (sparse) | * | T2N0M0 | IB | Malignant | * |
L11 | 187 | 56 | M | Pancreas | Neuroendocrine carcinoma | * | T2N0M0 | IB | Malignant | * |
L12 | 188 | 28 | M | Pancreas | Neuroendocrine carcinoma | * | T2N1M0 | IIIA | Malignant | * |
L13 | 189 | 47 | F | Pancreas | Neuroendocrine carcinoma | * | T3N0M0 | IIA | Malignant | 5.0 |
L14 | 190 | 56 | F | Pancreas | Sarcomatoid carcinoma | * | T3N0M0 | IIA | Malignant | 5*3*3 |